111 (YI) Receivables - Other (2018 - 2019)
111 (YI) posted Receivables - Other of $86831.0 for Q4 2019, up 282.4% sequentially from $22706.8 in Q4 2018, and up 282.4% YoY from $22706.8 in Q4 2018.
111 (YI) Receivables - Other (2018 - 2019) Analysis & Trends
111 has reported Receivables - Other for 2 years, with the latest figure at $86831.0 in Q4 2019.
- Quarterly Receivables - Other rose 282.4% year-over-year to $86831.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $86831.0 (up 282.4% YoY) and the FY2019 annual result came in at $88634.7, down 72.44% from the prior year.
- Receivables - Other improved to $86831.0 in Q4 2019 per YI's latest filing, from $22706.8 in the prior quarter.
- Over five years, Receivables - Other peaked at $86831.0 in Q4 2019 and troughed at $22706.8 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 101.90 Bn | 96.74 Bn | 3.69 Bn |
| 2 | Cencora | 61.60 Bn | 58.78 Bn | 3.61 Bn |
| 3 | Cardinal Health | 54.21 Bn | 49.35 Bn | 2.56 Bn |
| 4 | Henry Schein | 10.08 Bn | 9.92 Bn | 1.10 Bn |
| 5 | Akso Health | 820.26 Mn | 820.04 Mn | - |
| 6 | Edap Tms | 156.78 Mn | 135.24 Mn | 7.34 Mn |
| 7 | Accendra Health | 94.72 Mn | 87.07 Mn | 263.41 Mn |
| 8 | 111 | 30.87 Mn | 109.39 Mn | 18.18 Mn |
| 9 | Cosmos Health | 13.40 Mn | 10.96 Mn | 1.51 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 86,831.03 |
| Dec 31, 2019 | 86,831.03 |
| Dec 31, 2018 | 22,706.85 |
| Dec 31, 2018 | 22,706.85 |